Viewing Study NCT00473993



Ignite Creation Date: 2024-05-05 @ 5:31 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00473993
Status: COMPLETED
Last Update Posted: 2009-02-16
First Post: 2007-05-15

Brief Title: Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich Switzerland
Sponsor: Seidenberg Arztpraxis A MD
Organization: Seidenberg Arztpraxis A MD

Study Overview

Official Title: Hepatitis C Bei Opioidabhängigen in Der Praxis Eine Querschnittsuntersuchung
Status: COMPLETED
Status Verified Date: 2007-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HepCOP
Brief Summary: Hepatitis C viral infection is common among opioid addicts in Zurich Switzerland The majority undergoes a maintenance treatment with methadone heroin or buprenorphine While stabilized by an opioid maintenance treatment OMTchronic hepatitis C can be treated with pegylated interferon plus ribavirin As not sufficiently known the results are comparable to the results of the treatment of nonaddicts

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C If not why are they not adequately investigated and treated Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich The patients files are revised and the involved doctors are asked through a structured interview
Detailed Description: wwwseidenbergchhepcoppdf

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None